{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": -9.583334, "regularMarketPrice": 2.17, "exchange": "NMS", "shortName": "Cyteir Therapeutics, Inc.", "longName": "Cyteir Therapeutics, Inc.", "messageBoardId": "finmb_284600473", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "firstTradeDateMilliseconds": 1624023000000, "priceHint": 4, "earningsTimestampEnd": 1647428340, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.45, "epsForward": -1.2, "epsCurrentYear": -1.18, "priceEpsCurrentYear": -1.8389832, "sharesOutstanding": 35667400, "bookValue": 4.119, "fiftyDayAverage": 1.9142, "fiftyDayAverageChange": 0.25580013, "fiftyDayAverageChangePercent": 0.13363291, "twoHundredDayAverage": 1.822, "twoHundredDayAverageChange": 0.34800005, "twoHundredDayAverageChangePercent": 0.19099893, "marketCap": 77398264, "forwardPE": -1.8083333, "priceToBook": 0.5268269, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-18", "averageAnalystRating": "2.7 - Hold", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.23000002, "regularMarketTime": 1684180804, "regularMarketDayHigh": 2.53, "regularMarketDayRange": "2.17 - 2.53", "regularMarketDayLow": 2.17, "regularMarketVolume": 48283, "regularMarketPreviousClose": 2.4, "bid": 0.0, "ask": 0.0, "bidSize": 22, "askSize": 10, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 2.4, "averageDailyVolume3Month": 56308, "averageDailyVolume10Day": 55270, "fiftyTwoWeekLowChange": 1.0400001, "fiftyTwoWeekLowChangePercent": 0.92035407, "fiftyTwoWeekRange": "1.13 - 4.22", "fiftyTwoWeekHighChange": -2.0499997, "fiftyTwoWeekHighChangePercent": -0.48578194, "fiftyTwoWeekLow": 1.13, "fiftyTwoWeekHigh": 4.22, "earningsTimestamp": 1647428340, "earningsTimestampStart": 1647428340, "displayName": "Cyteir Therapeutics", "symbol": "CYT"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "128 Spring Street", "address2": "Building A Suite 510", "city": "Lexington", "state": "MA", "zip": "02421", "country": "United States", "phone": "857 285 4140", "website": "https://cyteir.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the oncology therapeutics. Its lead product CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. Cyteir Therapeutics, Inc. was incorporated in 2012 and is headquartered in Lexington, Massachusetts.", "fullTimeEmployees": 46, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph S. Zakrzewski", "age": 60, "title": "Independent Investor & Independent Chairman", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 81500, "fmt": "81.5k", "longFmt": "81,500"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Markus F. Renschler M.D.", "age": 61, "title": "Pres, CEO & Director", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 718620, "fmt": "718.62k", "longFmt": "718,620"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Timothy  Romberger", "age": 50, "title": "Independent Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 43216, "fmt": "43.22k", "longFmt": "43,216"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Adam M. Veness Esq.", "age": 36, "title": "Gen. Counsel & Sec.", "yearBorn": 1986, "fiscalYear": 2022, "totalPay": {"raw": 492129, "fmt": "492.13k", "longFmt": "492,129"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kevin  Mills Ph.D.", "title": "Co-Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. David G. Gaiero", "age": 43, "title": "CFO & Treasurer", "yearBorn": 1979, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Tom  O'Shea Ph.D.", "title": "Sr. VP of Clinical Pharmacology & Preclinical Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Krisztina  Nemenyi Ph.D.", "title": "Sr. VP of Regulatory Affairs and Quality", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}